Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VTRS

Viatris (VTRS)

Viatris Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTRS
DateTimeSourceHeadlineSymbolCompany
05/21/20245:59AMPR Newswire (US)Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at ScaleNASDAQ:VTRSViatris Inc
05/09/20246:47AMIH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:VTRSViatris Inc
05/09/20246:44AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
05/09/20245:59AMPR Newswire (US)Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance RangesNASDAQ:VTRSViatris Inc
05/02/20244:00PMPR Newswire (US)Viatris to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:VTRSViatris Inc
05/01/20245:59AMPR Newswire (US)Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthNASDAQ:VTRSViatris Inc
04/16/20243:30PMPR Newswire (US)Viatris to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTRSViatris Inc
04/15/20247:00AMPR Newswire (US)Viatris Appoints Corinne Le Goff as Chief Commercial OfficerNASDAQ:VTRSViatris Inc
04/15/20245:59AMPR Newswire (Canada)Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in CanadaNASDAQ:VTRSViatris Inc
04/15/20245:59AMPR Newswire (Canada)Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au CanadaNASDAQ:VTRSViatris Inc
04/01/20245:59AMPR Newswire (US)Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United StatesNASDAQ:VTRSViatris Inc
03/27/20245:59AMPR Newswire (US)Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its PipelineNASDAQ:VTRSViatris Inc
03/05/20247:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
03/05/20247:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
03/05/20247:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
03/05/20246:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
03/05/20246:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
03/05/20246:26PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
03/04/20245:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
02/28/20246:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
02/28/20245:30AMPR Newswire (US)Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceNASDAQ:VTRSViatris Inc
02/28/202412:00AMPR Newswire (US)Viatris and Idorsia Enter Into Significant Global Research and Development CollaborationNASDAQ:VTRSViatris Inc
02/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
02/16/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
02/15/20244:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
02/05/20245:59AMPR Newswire (US)Viatris to Announce Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:VTRSViatris Inc
01/30/20243:40PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VTRSViatris Inc
01/19/20245:56AMPR Newswire (US)Viatris recognised as a Top Employer 2024 in the UK for the second consecutive yearNASDAQ:VTRSViatris Inc
01/05/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
01/04/20247:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
 Showing the most relevant articles for your search:NASDAQ:VTRS

Your Recent History

Delayed Upgrade Clock